![Michael Davidson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 25 M $ as of 31/07/2026
Michael H.
Davidson founded Trofi Nutritionals, Inc. in 2021, where he worked as Director & Chief Scientific Officer, Chicago Center for Clinical Research in 1987, where he worked as President & Chief Executive Officer from 1987 to 2008, Corvidia Therapeutics, Inc. in 2016, where he worked as Chief Scientific & Medical Officer from 2018 to 2020, and various other companies.
Dr. Davidson also currently works at NewAmsterdam Pharma BV, as Chief Executive Officer & Executive Director from 2020, NewAmsterdam Pharma Holding BV, as Chief Executive Officer & Executive Director from 2020, NewAmsterdam Pharma Co. NV, as Chief Executive Officer & Director, and various other companies.
Dr. Davidson also formerly worked at ABIONYX Pharma SA, as Independent Director from 2015 to 2019, Caladrius Biosciences, Inc., as Independent Director, Cerenis Therapeutics, Inc., as Director from 2015 to 2019, and various other companies.
Dr. Davidson received his undergraduate degree from Northwestern University and doctorate degree from The Ohio State University College of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/04/2026 | 905,286 ( 0.77% ) | 25 M $ | 31/07/2026 | |
| 08/04/2026 | 2,881 ( 0.01% ) | 39 470 $ | 31/07/2026 | |
BIOAGE LABS, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Director/Board Member | 01/04/2021 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Chief Executive Officer | 01/11/2022 |
| BIOAGE LABS, INC. | Director/Board Member | 01/03/2024 |
NewAmsterdam Pharma Corp.
 NewAmsterdam Pharma Corp. BiotechnologyHealth Technology Develops therapies in the fields of metabolic diseases, cardiovascular diseases, and liver diseases | Chief Executive Officer | 01/08/2020 |
NanoPhoria Srl
 NanoPhoria Srl BiotechnologyHealth Technology Operates as a preclinical stage biotech company that develops non-viral drug delivery platform | Director/Board Member | - |
SonoThera, Inc.
 SonoThera, Inc. Pharmaceuticals: MajorHealth Technology Develops ultrasound-mediated non-viral genetic medicine to treat the root cause of human diseases | Founder | 01/01/2022 |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Chief Executive Officer | 01/08/2020 |
Jocasta Neuroscience, Inc.
 Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company that specializes in developing therapies for cognitive impairment associated with neurodegenerative diseases | Founder | 01/01/2021 |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 29 |
|---|---|
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Sonogene LLC | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Chicago Center for Clinical Research
 Chicago Center for Clinical Research Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
American College of Chest Physicians
 American College of Chest Physicians Miscellaneous Commercial ServicesCommercial Services Operates as chest medical associations | Commercial Services |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
Preventive Cardiology Institute, Inc.
 Preventive Cardiology Institute, Inc. The Preventive Cardiology Institute, Inc. is a company based in Napa, CA. | |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Abcentra, Inc.
 Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops oxidized LDL blocking therapeutics for cardiovascular inflammation treatment | Commercial Services |
National Lipid Association
 National Lipid Association Miscellaneous Commercial ServicesCommercial Services Operates medical society focused on enhancing the practice of lipid management in clinical medicine | Commercial Services |
Midwest Lipid Association | |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Health Technology |
The Ohio State University College of Medicine
 The Ohio State University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Inositec AG
 Inositec AG Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops treatments for progressive vascular calcification and soft tissue disorders | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
The University of Chicago Department of Medicine
 The University of Chicago Department of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases | Health Technology |
Jocasta Neuroscience, Inc.
Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company that specializes in developing therapies for cognitive impairment associated with neurodegenerative diseases | Health Technology |
NanoPhoria Srl
NanoPhoria Srl BiotechnologyHealth Technology Operates as a preclinical stage biotech company that develops non-viral drug delivery platform | Health Technology |
Trofi Nutritionals, Inc.
 Trofi Nutritionals, Inc. Specialty StoresRetail Trade Provides personal health services | Retail Trade |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
SonoThera, Inc.
SonoThera, Inc. Pharmaceuticals: MajorHealth Technology Develops ultrasound-mediated non-viral genetic medicine to treat the root cause of human diseases | Health Technology |
NewAmsterdam Pharma Corp.
NewAmsterdam Pharma Corp. BiotechnologyHealth Technology Develops therapies in the fields of metabolic diseases, cardiovascular diseases, and liver diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
